Literature DB >> 19279184

Incorporation of 5-chlorocytosine into mammalian DNA results in heritable gene silencing and altered cytosine methylation patterns.

Victoria Valinluck Lao1, Jason L Herring, Cherine H Kim, Agus Darwanto, Ubaldo Soto, Lawrence C Sowers.   

Abstract

Cytosine methylation patterns are essential for the proper control of gene expression in higher vertebrates. Although alterations in methylation patterns are frequently observed in human tumors, neither the mechanisms for establishing methylation patterns during normal development nor the mechanisms leading to pathological alterations of methylation patterns are currently known. While epidemiological studies have implicated inflammation in cancer etiology, a mechanistic link has yet to be established. Investigations of inflammation-mediated DNA damage may have provided important new insights. Our in vitro studies revealed that the inflammation-mediated DNA damage product, 5-chlorocytosine, could direct fraudulent methylation of previously unmethylated CpG sites. The purpose of this study was to recapitulate our in vitro findings by introducing 5-chlorocytosine residues into the DNA of replicating mammalian cells and to examine its impact on gene expression and cytosine methylation patterns. CHO-K1 cells hemizygous for the hprt gene were electroporated with the triphosphates of cytosine [2'-deoxycytidine-5'-triphosphate (dCTP)], 5-methylcytosine [5-methyl-2'-deoxycytidine-5'-triphosphate (MedCTP)] and 5'-chloro-2'-deoxycytidine-5'-triphosphate (CldCTP), and then selected with 6-thioguanine for silencing the hprt gene. Both modified nucleotides, MedCTP and CldCTP, but not unmodified dCTP, silenced hprt gene expression. Subsequent bisulfite pyrosequencing of CpG sites within the hprt promoter region of the selected cells confirmed hypermethylation, although global methylation levels as measured by gas chromatography-mass spectrometry did not change. Modified nucleotide-induced gene silencing could be reversed with 5-aza-2'-deoxycytidine indicating an epigenetic rather than mutagenic alteration. These results provide further evidence that the inflammation damage product 5-chlorocytosine could be a link between inflammation and cancer development.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19279184      PMCID: PMC2675655          DOI: 10.1093/carcin/bgp060

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  46 in total

1.  Molecular chlorine generated by the myeloperoxidase-hydrogen peroxide-chloride system of phagocytes produces 5-chlorocytosine in bacterial RNA.

Authors:  J P Henderson; J Byun; J W Heinecke
Journal:  J Biol Chem       Date:  1999-11-19       Impact factor: 5.157

2.  Production of brominating intermediates by myeloperoxidase. A transhalogenation pathway for generating mutagenic nucleobases during inflammation.

Authors:  J P Henderson; J Byun; M V Williams; D M Mueller; M L McCormick; J W Heinecke
Journal:  J Biol Chem       Date:  2000-11-28       Impact factor: 5.157

Review 3.  Gene silencing in cancer in association with promoter hypermethylation.

Authors:  James G Herman; Stephen B Baylin
Journal:  N Engl J Med       Date:  2003-11-20       Impact factor: 91.245

4.  Neutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis.

Authors:  J P Gaut; G C Yeh; H D Tran; J Byun; J P Henderson; G M Richter; M L Brennan; A J Lusis; A Belaaouaj; R S Hotchkiss; J W Heinecke
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

5.  Detection of chlorinated DNA and RNA nucleosides by HPLC coupled to tandem mass spectrometry as potential biomarkers of inflammation.

Authors:  Carine Badouard; Mitsuharu Masuda; Hoyoku Nishino; Jean Cadet; Alain Favier; Jean-Luc Ravanat
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2005-04-18       Impact factor: 3.205

6.  3-Chlorotyrosine as a marker of protein damage by myeloperoxidase in tracheal aspirates from preterm infants: association with adverse respiratory outcome.

Authors:  I Hendrikje Buss; Revathy Senthilmohan; Brian A Darlow; Nina Mogridge; Anthony J Kettle; Christine C Winterbourn
Journal:  Pediatr Res       Date:  2003-03       Impact factor: 3.756

7.  DNA recognition by the methyl-CpG binding domain of MeCP2.

Authors:  A Free; R I Wakefield; B O Smith; D T Dryden; P N Barlow; A P Bird
Journal:  J Biol Chem       Date:  2000-10-16       Impact factor: 5.157

8.  Synthesis of stable-isotope enriched 5-methylpyrimidines and their use as probes of base reactivity in DNA.

Authors:  Artur Burdzy; Katherine T Noyes; Victoria Valinluck; Lawrence C Sowers
Journal:  Nucleic Acids Res       Date:  2002-09-15       Impact factor: 16.971

9.  DNA hypomethylation, cancer, the immunodeficiency, centromeric region instability, facial anomalies syndrome and chromosomal rearrangements.

Authors:  Melanie Ehrlich
Journal:  J Nutr       Date:  2002-08       Impact factor: 4.798

Review 10.  DNA methylation and epigenetic inheritance.

Authors:  Robin Holliday; Thu Ho
Journal:  Methods       Date:  2002-06       Impact factor: 3.608

View more
  19 in total

1.  Epigenetics of chronic rhinosinusitis and the role of the eosinophil.

Authors:  Kristin A Seiberling; Christopher A Church; Jason L Herring; Lawrence C Sowers
Journal:  Int Forum Allergy Rhinol       Date:  2011-08-26       Impact factor: 3.858

Review 2.  Microbiota impact on the epigenetic regulation of colorectal cancer.

Authors:  Tao Yang; Jennifer L Owen; Yaíma L Lightfoot; Michael P Kladde; Mansour Mohamadzadeh
Journal:  Trends Mol Med       Date:  2013-09-16       Impact factor: 11.951

3.  Infection-induced colitis in mice causes dynamic and tissue-specific changes in stress response and DNA damage leading to colon cancer.

Authors:  Aswin Mangerich; Charles G Knutson; Nicola M Parry; Sureshkumar Muthupalani; Wenjie Ye; Erin Prestwich; Liang Cui; Jose L McFaline; Melissa Mobley; Zhongming Ge; Koli Taghizadeh; John S Wishnok; Gerald N Wogan; James G Fox; Steven R Tannenbaum; Peter C Dedon
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-11       Impact factor: 11.205

4.  MicroRNA-137 promoter methylation in oral rinses from patients with squamous cell carcinoma of the head and neck is associated with gender and body mass index.

Authors:  Scott M Langevin; Roslyn A Stone; Clareann H Bunker; Jennifer R Grandis; Robert W Sobol; Emanuela Taioli
Journal:  Carcinogenesis       Date:  2010-03-02       Impact factor: 4.944

Review 5.  Chemistry meets biology in colitis-associated carcinogenesis.

Authors:  A Mangerich; P C Dedon; J G Fox; S R Tannenbaum; G N Wogan
Journal:  Free Radic Res       Date:  2013-10-04

6.  Cancer DNA methylation: molecular mechanisms and clinical implications.

Authors:  Michael T McCabe; Johann C Brandes; Paula M Vertino
Journal:  Clin Cancer Res       Date:  2009-06-09       Impact factor: 12.531

7.  Comparison of the structural and dynamic effects of 5-methylcytosine and 5-chlorocytosine in a CpG dinucleotide sequence.

Authors:  Jacob A Theruvathu; Y Whitney Yin; B Montgomery Pettitt; Lawrence C Sowers
Journal:  Biochemistry       Date:  2013-11-11       Impact factor: 3.162

8.  Intrinsic mutagenic properties of 5-chlorocytosine: A mechanistic connection between chronic inflammation and cancer.

Authors:  Bogdan I Fedeles; Bret D Freudenthal; Emily Yau; Vipender Singh; Shiou-chi Chang; Deyu Li; James C Delaney; Samuel H Wilson; John M Essigmann
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-04       Impact factor: 11.205

9.  Chemical and cytokine features of innate immunity characterize serum and tissue profiles in inflammatory bowel disease.

Authors:  Charles G Knutson; Aswin Mangerich; Yu Zeng; Arkadiusz R Raczynski; Rosa G Liberman; Pilsoo Kang; Wenjie Ye; Erin G Prestwich; Kun Lu; John S Wishnok; Joshua R Korzenik; Gerald N Wogan; James G Fox; Peter C Dedon; Steven R Tannenbaum
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-10       Impact factor: 11.205

Review 10.  Inflammation-induced DNA damage, mutations and cancer.

Authors:  Jennifer Kay; Elina Thadhani; Leona Samson; Bevin Engelward
Journal:  DNA Repair (Amst)       Date:  2019-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.